Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SUBSTANTIA NIGRA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 3900 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kozlowski, DA; Bremer, E; Redmond, DE; George, D; Larson, B; Bohn, MC
      Quantitative analysis of transgene protein, mRNA, and vector DNA followinginjection of an adenoviral vector harboring glial cell line-derived neurotrophic factor into the primate caudate nucleus

      MOLECULAR THERAPY
    2. Goedert, M
      Alpha-synuclein and neurodegenerative diseases

      NATURE REVIEWS NEUROSCIENCE
    3. Beal, MF
      Experimental models of Parkinson's disease

      NATURE REVIEWS NEUROSCIENCE
    4. Dunnett, SB; Bjorklund, A; Lindvall, O
      Cell therapy in Parkinson's disease - stop or go?

      NATURE REVIEWS NEUROSCIENCE
    5. Lindvall, O; Hagell, P
      Cell therapy and transplantation in Parkinson's disease

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    6. Legendre, P
      The glycinergic inhibitory synapse

      CELLULAR AND MOLECULAR LIFE SCIENCES
    7. Jung, YJ; Youn, JY; Ryu, JC; Surh, YJ
      Salsolinol, a naturally occurring tetrahydroisoquinoline alkaloid, inducesDNA damage and chromosomal aberrations in cultured Chinese hamster lung fibroblast cells

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    8. Mattson, MP; Duan, W; Pedersen, WA; Culmsee, C
      Neurodegenerative disorders and ischemic brain diseases

      APOPTOSIS
    9. Drukarch, B; van Muiswinkel, FL
      Neuroprotection for Parkinson's disease: a new approach for a new millennium

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    10. Cadet, JL
      Molecular neurotoxicological models of Parkinsonism: focus on genetic manipulation of mice

      PARKINSONISM & RELATED DISORDERS
    11. Gearan, T; Castillo, OA; Schwarzschild, MA
      The parkinsonian neurotoxin, MPP+ induces phosphorylated c-Jun in dopaminergric neurons of mesencephalic cultures

      PARKINSONISM & RELATED DISORDERS
    12. Parent, A; Levesque, M; Parent, M
      A re-evaluation of the current model of the basal ganglia

      PARKINSONISM & RELATED DISORDERS
    13. Isacson, O; Costantini, L; Schumacher, JM; Cicchetti, F; Chung, S; Kim, SK
      Cell implantation therapies for Parkinson's disease using neural stem, transgenic or xenogeneic donor cells

      PARKINSONISM & RELATED DISORDERS
    14. Rayport, S
      Glutamate is a cotransmitter in ventral midbrain dopamine neurons

      PARKINSONISM & RELATED DISORDERS
    15. Fredriksson, A; Schroder, N; Eriksson, P; Izquierdo, I; Archer, T
      Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits

      PARKINSONISM & RELATED DISORDERS
    16. Vila, M; Jackson-Lewis, V; Guegan, C; Wu, DC; Teismann, P; Choi, DK; Tieu, K; Przedborski, S
      The role of glial cells in Parkinson's disease

      CURRENT OPINION IN NEUROLOGY
    17. Fiszer, U
      Does Parkinson's disease have an immunological basis? The evidence and itstherapeutic implications

      BIODRUGS
    18. Le, WD; Jankovic, J
      Are dopamine receptor agonists neuroprotective in Parkinson's disease?

      DRUGS & AGING
    19. Clarkson, ED
      Fetal tissue transplantation for patients with Parkinson's disease - A database of published clinical results

      DRUGS & AGING
    20. Paladini, CA; Fiorillo, CD; Morikawa, H; Williams, JT
      Amphetamine selectively blocks inhibitory glutamate transmission in dopamine neurons

      NATURE NEUROSCIENCE
    21. Purkerson-Parker, S; McDaniel, KL; Moser, VC
      Dopamine transporter binding in the rat striatum is increased by gestational, perinatal, and adolescent exposure to heptachlor

      TOXICOLOGICAL SCIENCES
    22. Pollack, M; Leeuwenburgh, C
      Apoptosis and aging: Role of the mitochondria

      JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
    23. Riolobos, AS; Heredia, M; de la Fuente, JA; Criado, JM; Yajeya, J; Campos, J; Santacana, M
      Functional recovery of skilled forelimb use in rats obliged to use the impaired limb after grafting of the frontal cortex lesion with homotopic fetalcortex

      NEUROBIOLOGY OF LEARNING AND MEMORY
    24. Vianna, DML; Graeff, FG; Landeira-Fernandez, J; Brandao, ML
      Lesion of the ventral periaqueductal gray reduces conditioned fear but does not change freezing induced by stimulation of the dorsal periaqueductal gray

      LEARNING & MEMORY
    25. Stromberg, I; Tornqvist, N; Johansson, S; Bygdeman, M; Almqvist, PM
      Evidence for target-specific outgrowth from subpopulations of grafted human dopamine neurons

      MICROSCOPY RESEARCH AND TECHNIQUE
    26. Zhang, ZM; Andersen, A; Grondin, R; Barber, T; Avison, R; Gerhardt, G; Gash, D
      Pharmacological MRI mapping of age-associated changes in basal ganglia circuitry of awake rhesus monkeys

      NEUROIMAGE
    27. Marvanova, M; Lakso, M; Pirhonen, J; Nawa, H; Wong, G; Castren, E
      The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain

      MOLECULAR AND CELLULAR NEUROSCIENCE
    28. Lee, JI; Shin, HJ; Nam, DH; Kim, JS; Hong, SC; Shin, HJ; Park, K; Eoh, W; Kim, JH; Lee, WY
      Increased burst firing in substantia nigra pars reticulata neurons and enhanced response to selective D2 agonist in hemiparkinsonian rats after repeated administration of apomorphine

      JOURNAL OF KOREAN MEDICAL SCIENCE
    29. Borlongan, CV; Zhou, FC; Hayashi, T; Su, TP; Hoffer, BJ; Wang, Y
      Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats

      NEUROBIOLOGY OF DISEASE
    30. Anichtchik, OV; Peitsaro, N; Rinne, JO; Kalimo, H; Panula, P
      Distribution and modulation of histamine H-3 receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease

      NEUROBIOLOGY OF DISEASE
    31. Callizot, N; Guenet, JL; Baillet, C; Warter, JM; Poindron, P
      The frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome

      NEUROBIOLOGY OF DISEASE
    32. Johansson, PA; Andersson, M; Andersson, KE; Cenci, MA
      Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of L-DOPA-induced dyskinesia

      NEUROBIOLOGY OF DISEASE
    33. Borlongan, CV; Su, TP; Wang, Y
      Delta opioid peptide augments functional effects and intrastriatal graft survival of rat fetal ventral mesencephalic cells

      CELL TRANSPLANTATION
    34. Farin, FM; Janssen, P; Quigley, S; Abbott, D; Hassett, C; Smith-Weller, T; Franklin, GM; Swanson, PD; Longstreth, WT; Omiecinski, CJ; Checkoway, H
      Genetic polymorphisms of microsomal and soluble epoxide hydrolase and the risk of Parkinson's disease

      PHARMACOGENETICS
    35. Ferger, B; Rose, S; Jenner, A; Halliwell, B; Jenner, P
      6-hydroxydopamine increases hydroxyl free radical production and DNA damage in rat striatum

      NEUROREPORT
    36. Datla, KP; Christidou, M; Widmer, WW; Rooprai, HK; Dexter, DT
      Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease

      NEUROREPORT
    37. Aguirre, JA; Andbjer, B; Gonzalez-Baron, S; Hansson, A; Stromberg, I; Agnati, LF; Fuxe, K
      Group I mGluR antagonist AIDA protects nigral DA cells from MPTP-induced injury

      NEUROREPORT
    38. Love, S
      Damage to nuclear DNA in Lewy body disease

      NEUROREPORT
    39. Zahran, AR; Simmerman, N; Carrier, S; Vachon, P
      Erectile dysfunction occurs following substantia nigra lesions in the rat

      INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH
    40. Kimmel, HL; Holtzman, SG
      Repeated cocaine administration does not alter morphine-induced rotationalbehavior in nigrally denervated rats

      BEHAVIOURAL PHARMACOLOGY
    41. Bennett, JP; Carvey, PM; Hinds, TR; Johnson, RD; Le, WD; Phillips, W; Sethy, VH; Vincenzi, FF; Youdim, MBH
      Mechanisms of action of pramipexole: Putative neuroprotective effects

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    42. MohanKumar, PS; MohanKumar, SMJ; Quadri, SK; Voogt, JL
      Effects of chronic bromocriptine treatment on tyrosine hydroxylase (TH) mRNA expression, TH activity and median eminence dopamine concentrations in ageing rats

      JOURNAL OF NEUROENDOCRINOLOGY
    43. Steiner, H; Kitai, ST
      Unilateral striatal dopamine depletion: time-dependent effects on corticalfunction and behavioural correlates

      EUROPEAN JOURNAL OF NEUROSCIENCE
    44. Berretta, N; Paolucci, E; Bernardi, G; Mercuri, NB
      Glutamate receptor stimulation induces a persistent rhythmicity of the GABAergic inputs to rat midbrain dopaminergic neurons

      EUROPEAN JOURNAL OF NEUROSCIENCE
    45. Crocker, SJ; Wigle, N; Liston, P; Thompson, CS; Lee, CJ; Xu, DG; Roy, S; Nicholson, DW; Park, DS; MacKenzie, A; Korneluk, RG; Robertson, GS
      NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6-OHDA rat model of Parkinson's disease

      EUROPEAN JOURNAL OF NEUROSCIENCE
    46. Metz, GAS; Farr, T; Ballermann, M; Whishaw, IQ
      Chronic levodopa therapy does not improve skilled reach accuracy or reach range on a pasta matrix reaching task in 6-OHDA dopamine-depleted (hemi-Parkinson analogue) rats

      EUROPEAN JOURNAL OF NEUROSCIENCE
    47. Haj-Dahmane, S
      D-2-like dopamine receptor activation excites rat dorsal raphe 5-HT neurons in vitro

      EUROPEAN JOURNAL OF NEUROSCIENCE
    48. Kirik, D; Georgievska, B; Rosenblad, C; Bjorklund, A
      Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease

      EUROPEAN JOURNAL OF NEUROSCIENCE
    49. Costantini, LC; Cole, D; Isacson, O
      Immunophilin ligands can prevent progressive dopaminergic degeneration in animal models of Parkinson's disease

      EUROPEAN JOURNAL OF NEUROSCIENCE
    50. Iravani, MM; Costa, S; Jackson, MJ; Tel, BC; Cannizzaro, C; Pearce, RKB; Jenner, P
      GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed commonmarmosets

      EUROPEAN JOURNAL OF NEUROSCIENCE
    51. Uslaner, J; Badiani, A; Norton, CS; Day, HEW; Watson, SJ; Akil, H; Robinson, TE
      Amphetamine and cocaine induce different patterns of c-fos mRNA expressionin the striatum and subthalamic nucleus depending on environmental context

      EUROPEAN JOURNAL OF NEUROSCIENCE
    52. Vaudano, E; Rosenblad, C; Bjorklund, A
      Injury induced c-Jun expression and phosphorylation in the dopaminergic nigral neurons of the rat: correlation with neuronal death and modulation by glial-cell-line-derived neurotrophic factor

      EUROPEAN JOURNAL OF NEUROSCIENCE
    53. Gonzalez-Hernandez, T; Barroso-Chinea, P; Acevedo, A; Salido, E; Rodriguez, M
      Colocalization of tyrosine hydroxylase and GAD65 mRNA in mesostriatal neurons

      EUROPEAN JOURNAL OF NEUROSCIENCE
    54. Satou, T; Anderson, AJ; Itoh, T; Tamai, Y; Hayashi, Y; Hashimoto, S
      Repetitive administration of tetrabenazine induces irreversible changes inlocomotion and morphology of the substantia nigra in rats

      EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
    55. Erhardt, S; Oberg, H; Mathe, JM; Engberg, G
      Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons

      AMINO ACIDS
    56. Quan, L; Zhu, BL; Oritani, S; Ishida, K; Fujita, MQ; Maeda, H
      Intranuclear ubiquitin immunoreactivity in the pigmented neurons of the substantia nigra in fire fatalities

      INTERNATIONAL JOURNAL OF LEGAL MEDICINE
    57. Sayre, LM; Smith, MA; Perry, G
      Chemistry and biochemistry of oxidative stress in neurodegenerative disease

      CURRENT MEDICINAL CHEMISTRY
    58. Araki, T; Mikami, T; Tanji, H; Matsubara, M; Imai, Y; Mizugaki, M; Itoyama, Y
      Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse

      EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    59. Rolletschek, A; Chang, H; Guan, KM; Czyz, J; Meyer, M; Wobus, AM
      Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors

      MECHANISMS OF DEVELOPMENT
    60. Bannon, MJ; Michelhaugh, SK; Wang, J; Sacchetti, P
      The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    61. Yoshida, S; Ektessabi, A; Fujisawa, S
      XANES spectroscopy of a single neuron from a patient with Parkinson's disease

      JOURNAL OF SYNCHROTRON RADIATION
    62. McHaffie, JG; Thomson, CM; Stein, BE
      Corticotectal and corticostriatal projections from the frontal eye fields of the cat: an anatomical examination using WGA-HRP

      SOMATOSENSORY AND MOTOR RESEARCH
    63. Puopolo, M; Hochstetler, SE; Gustincich, S; Wightman, RM; Raviola, E
      Extrasynaptic release of dopamine in a retinal neuron: Activity dependenceand transmitter modulation

      NEURON
    64. Yu, MF; Lin, TY; Ho, WH; Yin, HS
      Amphetamine induces differential changes in the gene expression of metabotropic glutamate receptor 5 in cultured cortical and hippocampal neurons

      JOURNAL OF MOLECULAR NEUROSCIENCE
    65. Smeyne, M; Goloubeva, O; Smeyne, RJ
      Strain-dependent susceptibility to MPTP and MPP+-induced parkinsonism is determined by glia

      GLIA
    66. Kimura, S; Kurasaki, M; Saito, T; Ito, K; Hosokawa, T; Okabe, M; Shiraishi, K; Niioka, T
      Effects of synthetic dopamine-melanins on oxygen radical - Formation induced by metal ions with dopamine

      NEUROSCIENCE RESEARCH COMMUNICATIONS
    67. Hemsley, KM; Crocker, AD
      Changes in muscle tone are regulated by D1 and D2 dopamine receptors in the ventral striatum and D1 receptors in the substantia nigra

      NEUROPSYCHOPHARMACOLOGY
    68. Ruskin, DN; Bergstrom, DA; Baek, D; Freeman, LE; Walters, JR
      Cocaine or selective block of dopamine transporters influences multisecondoscillations in firing rate in the globus pallidus

      NEUROPSYCHOPHARMACOLOGY
    69. Moore, H; Rose, HJ; Grace, AA
      Chronic cold stress reduces the spontaneous activity of ventral tegmental dopamine neurons

      NEUROPSYCHOPHARMACOLOGY
    70. Lee, FJS; Liu, F; Pristupa, ZB; Niznik, HB
      Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis

      FASEB JOURNAL
    71. Dabbeni-Sala, F; Di Santo, S; Franceschini, D; Skaper, SD; Giusti, P
      Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity

      FASEB JOURNAL
    72. Mendez-Alvarez, E; Soto-Otero, R; Hermida-Ameijeiras, A; Lopez-Martin, ME; Labandeira-Garcia, JL
      Effect of iron and manganese on hydroxyl radical production by 6-hydroxydopamine: Mediation of antioxidants

      FREE RADICAL BIOLOGY AND MEDICINE
    73. Lin, AMY
      Coexistence of zinc and iron augmented oxidative injuries in the nigrostriatal dopaminergic system of SD rats

      FREE RADICAL BIOLOGY AND MEDICINE
    74. Chauhan, NB; Siegel, GJ; Lee, JM
      Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain

      JOURNAL OF CHEMICAL NEUROANATOMY
    75. Mink, JW
      Basal ganglia dysfunction in Tourette's syndrome: A new hypothesis

      PEDIATRIC NEUROLOGY
    76. Suzuki, M; Desmond, TJ; Albin, RL; Frey, KA
      Vesicular neurotransmitter transporters in Huntington's disease: Initial observations and comparison with traditional synaptic markers

      SYNAPSE
    77. Morrow, BA; Elsworth, JD; Roth, RH
      Prenatal exposure to cocaine reduces the number and enhances reactivity ofA10 dopaminergic neurons to environmental stress

      SYNAPSE
    78. Callier, S; Morissette, M; Grandbois, M; Pelaprat, D; Di Paolo, T
      Neuroprotective properties of 17 beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice

      SYNAPSE
    79. Tajiri, K; Emori, K; Murata, R; Tanaka, K; Suzuki, M; Uehara, T; Sumiyoshi, T; Ashby, CR; Kurachi, M
      Intracerebroventricular administration of NMDA-R1 antisense oligodeoxynucleotide significantly alters the activity of ventral tegmental area dopamineneurons: An electrophysiological study

      SYNAPSE
    80. Nissbrandt, H; Bergquist, F; Jonason, J; Engberg, G
      Inhibition of cytochrome P450 2E1 induces an increase in extracellular dopamine in rat substantia nigra: A new metabolic pathway?

      SYNAPSE
    81. Svingos, AL; Colago, EEO; Pickel, VM
      Vesicular acetylcholine transporter in the rat nucleus accumbens shell: Subcellular distribution and association with mu-opioid receptors

      SYNAPSE
    82. Rinne, JO; Nurmi, E; Ruottinen, HM; Bergman, J; Eskola, O; Solin, O
      [F-18]FDOPA and [F-18]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease

      SYNAPSE
    83. Olds, ME; Jacques, DB; Kopyov, O
      Entopeduncular lesions facilitate and thalamic lesions depress spontaneousand drug-evoked motor behavior in the hemiparkinsonian rat

      SYNAPSE
    84. Calon, F; Lavertu, N; Lemieux, AM; Morissette, M; Goulet, M; Grondin, R; Blanchet, PJ; Bedard, PJ; Di Paolo, T
      Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: Correlation with dopamine concentrations and dopamine transporter

      SYNAPSE
    85. Minabe, Y; Hashimoto, K; Watanabe, K; Ashby, CR
      Acute and repeated administration of the selective 5-HT2A receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons:An in vivo electrophysiological study

      SYNAPSE
    86. Ni, ZG; Bouali-Benazzouz, R; Gao, DM; Benabid, AL; Benazzouz, A
      Intrasubthalamic injection of 6-hydroxydopamine induces changes in the firing rate and pattern of subthalamic nucleus neurons in the rat

      SYNAPSE
    87. Schmidt, N; Ferger, B
      Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease

      SYNAPSE
    88. Frechilla, D; Cobreros, A; Saldise, L; Moratalla, R; Insausti, R; Luquin, MR; Del Rio, J
      Serotonin 5-HT1A receptor expression is selectively enhanced in the striosomal compartment of chronic parkinsonian monkeys

      SYNAPSE
    89. Hoffman, RE; Shi, WX; Bunney, BS
      Anatomic basis of sequence-dependent predictability exhibited by nigral dopamine neuron firing patterns

      SYNAPSE
    90. Sakai, K; Gao, XM; Hashimoto, T; Tamminga, CA
      Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways

      SYNAPSE
    91. Teismann, P; Ferger, B
      Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease

      SYNAPSE
    92. Dawson, NM; Hamid, EH; Egan, MF; Meredith, GE
      Changes in the pattern of brain-derived neurotrophic factor immunoreactivity in the rat brain after acute and subchronic haloperidol treatment

      SYNAPSE
    93. Londos, E; Passant, U; Gustafson, L; Brun, A
      Neuropathological correlates to clinically defined dementia with Lewy bodies

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    94. Varrone, A; Marek, KL; Jennings, D; Innis, RB; Seibyl, JP
      [I-123]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy

      MOVEMENT DISORDERS
    95. Yee, RE; Irwin, I; Milonas, C; Stout, DB; Huang, SC; Shoghi-Jadid, K; Satyamurthy, N; Delanney, LE; Togaski, DM; Farahani, KF; Delfani, K; Janson, AM; Phelps, ME; Langston, JW; Barrio, JR
      Novel observations with FDOPA-PET imaging after early nigrostriatal damage

      MOVEMENT DISORDERS
    96. Nurmi, E; Ruottinen, HM; Bergman, J; Haaparanta, M; Solin, O; Sonninen, P; Rinne, JO
      Rate of progression in Parkinson's disease: A 6-[F-18]fluoro-L-dopa PET study

      MOVEMENT DISORDERS
    97. Datla, KP; Blunt, SB; Dexter, DT
      Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, inrats with partial 6-OHDA or FeCl3 nigrostriatal lesions

      MOVEMENT DISORDERS
    98. Muriel, MP; Agid, Y; Hirsch, E
      Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease

      MOVEMENT DISORDERS
    99. Turmel, H; Hartmann, A; Parain, K; Douhou, A; Srinivasan, A; Agid, Y; Hirsch, EC
      Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice

      MOVEMENT DISORDERS
    100. Becker, G; Berg, D
      Neuroimaging in basal ganglia disorders: Perspectives for transcranial ultrasound

      MOVEMENT DISORDERS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 14:55:24